On the 21st, the KOSPI index turned upward during the session due to the buying trend of foreign investors. The KOSDAQ index is showing slight weakness as HLB Group's shares recorded consecutive lower limits (the lowest daily price limit) due to the impact of the U.S. Food and Drug Administration (FDA) rejection of the liver cancer drug.
As of 11:20 a.m. on this day, the KOSPI index is trading at 2640.88, up 3.78 points (0.14%) from the previous day. In the securities market, foreign investors are net buying 404.1 billion won. Institutions and individuals are selling 231.8 billion won and 209.3 billion won, respectively.
Among the top market capitalization stocks, SK hynix is showing a strong performance of around 4%, while Samsung Electronics (1.83%), Kia (1.46%), Samsung Electronics preferred shares (1.40%), Hyundai Motor (0.99%), and Naver (0.24%) are also rising. LG Energy Solution (-1.20%), Celltrion (-0.59%), and KB Financial (-0.12%) are declining.
Hanwha Aerospace is down more than 11% amid a 3.6 trillion won capital increase effect.
At the same time, the KOSDAQ index is trading at 721.28, down 3.87 points (0.53%) from the previous day. In the KOSDAQ market, individuals are net selling 91.4 billion won, while institutions and foreign investors are net buying 83.7 billion won and 12.3 billion won, respectively.
In the top KOSDAQ market capitalization stocks, HLB plummeted 29.97%. Rainbow Robotics (-3.81%), ECOPRO BM (-1.24%), and CLASSYS (-0.51%) are also seeing declines. In contrast, Kolon TissueGene (6.67%), Sam Chun Dang Pharm (5.42%), LigaChem Biosciences (2.33%), HUGEL (0.91%), Ecopro (0.50%), and Alteogen (0.13%) are on the rise.
In the Seoul foreign exchange market, the won (KRW) exchange rate against the U.S. dollar is trading at 1467.2 won, up 0.50 won from the previous trading day at the same time.